The Clinical Pharmacokinetics of Itraconazole: An Overview

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Mycoses (Berlin)

• Publication date

  1989-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1439-0507.1989.tb02296.xPMID 2561187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects

  2004cited by this paper
• Induction potential of fluconazole toward drug-metabolizing enzymes in rats

  1990cited by this paper
• Fluconazole is a potent inhibitor of antipyrine metabolism in vivo in mice.

  1989cited by this paper
• Fluconazole and phenytoin: a predictable interaction.

  1989cited by this paper
• INTERACTION OF FLUCONAZOLE WITH CYCLOSPORIN

  1989cited by this paper
• Interference of antimycotics and other drugs with methohexital hypnosis in rats

  1989cited by this paper
• Interaction of fluconazole with cyclosporin.

  1989cited by this paper
• Experience with itraconazole in cryptococcosis and aspergillosis.

  1989cited by this paper
• In-vivo effects of itraconazole on hepatic mixed-function oxidase.

  1988cited by this paper
• Itraconazole pharmacokinetics in patients with renal dysfunction

  1988cited by this paper
• Pharmacokinetic profile of orally administered itraconazole in human skin.

  1988cited by this paper
• Comparison of high performance liquid chromatographic and microbiological methods for determination of itraconazole.

  1988cited by this paper
• An evaluation of itraconazole in the management of onychomycosis

  1988cited by this paper
• Fluconazole in the treatment of candidal prosthetic valve endocarditis.

  1988cited by this paper
• Determination of cisapride in plasma and animal tissues by high-performance liquid chromatography.

  1988cited by this paper
• Pharmacokinetics of itraconazole following oral administration to normal volunteers

  1988cited by this paper
• Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

  1988cited by this paper
• Interaction of cyclosporin and itraconazole.

  1987cited by this paper
• The pharmacokinetics of itraconazole in animals and man: an overview

  1987cited by this paper
• Determination of itraconazole in plasma and animal tissues by high-performance liquid chromatography.

  1987cited by this paper
• Recent Trends in the Discovery, Development, and Evaluation of Antifungal Agents

  1987cited by this paper
• Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.

  1987cited by this paper
• Interaction of miconazole, ketoconazole and itraconazole with rat-liver microsomes.

  1987cited by this paper
• Time course of cyclosporin/itraconazole interaction.

  1987cited by this paper
• Interaction of cyclosporin and itraconazole.

  1987cited by this paper
• Itraconazole in the treatment of human mycoses: review of three years of clinical experience.

  1987cited by this paper
• Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.

  1987cited by this paper
• Itraconazole and cyclosporin nephrotoxicity.

  1987cited by this paper
• Itraconazole pharmacokinetics in the female genital tract: plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole.

  1986cited by this paper
• Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.

  1986cited by this paper
• Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits.

  1985cited by this paper
• Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans

  1985cited by this paper
• Molecular basis for the antimycotic and antibacterial activity of N‐substituted imidazoles and triazoles: The inhibition of isoprenoid biosynthesis

  1984cited by this paper
• Orally administered ketoconazole: route of delivery to the human stratum corneum

  1983cited by this paper
• Interaction of rifampicin with other drugs.

  1980cited by this paper
• Griseofulvin levels in stratum corneum. Study after oral administration in man.

  1972cited by this paper
• Determination of griseofulvin in skin, plasma, and sweat.

  1972cited by this paper

• Fabrication and Evaluation of Itraconazole Particulate Drug Delivery System

  2026cites this paper
• Therapeutic drug monitoring of itraconazole in treatment of blastomycosis in dogs.

  2026cites this paper
• In Vitro-In Vivo Correlation Of Amorphous Solid Dispersion Enabled Itraconazole Tablets

  2025influential citation
• Combining high throughput ASD screening with the rDCS to streamline development of poorly soluble drugs.

  2025cites this paper
• Epithelial-mesenchymal transition in cancer: A focus on itraconazole, a hedgehog inhibitor.

  2025cites this paper
• A physiologically based biopharmaceutics modeling (PBBM) framework for characterizing formulation-dependent food effects: paving the road towards fed virtual BE studies for itraconazole amorphous solid dispersions.

  2025cites this paper
• Antifungal susceptibility testing and determination of local epidemiological cut-off values for Candida species isolated from women with vulvovaginal candidiasis

  2025influential citation
• Evaluation of drug-drug interaction between Suraxavir Marboxil (GP681) and itraconazole, and assessment of the impact of gene polymorphism

  2025cites this paper
• Pharmacological Management of Oral and Esophageal Candidiasis: A Clinical Pharmacotherapy Perspective

  2025cites this paper
• Drug repurposing of 6-AZA-UTP and itraconazole reveals novel B3GALT5 inhibitors for pancreatic cancer.

  2025cites this paper
• Central composite design-assisted development and validation of a stability-indicating instrumental thin-layer chromatography method for the quantification of itraconazole in tablet dosage form using BAGI and GAPI tools

  2025cites this paper
• From simulation to application: enhancing preclinical evaluation of dissolvable microarray patches through PBPK modelling.

  2025cites this paper
• Assessing Impact of Food on Oral Drug Bioequivalence Supporting ICH M13 A with the Advancements of Physiologically Based Pharmacokinetic Modeling

  2025cites this paper
• Mycetoma managment: Therapeutic challenges and the role of pharmacovigilance

  2025cites this paper
• Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series

  2025cites this paper
• Utility of Itraconazole in Combination with Liposomal Amphotericin B in Rhizopus oryzae Associated Mucormycosis–An Exploratory Study

  2024cites this paper
• Relative Performance of Volume of Distribution Prediction Methods for Lipophilic Drugs with Uncertainty in LogP Value

  2024cites this paper
• Invasive fungal infections and oomycoses in cats 2. Antifungal therapy

  2024cites this paper
• Single and joint toxicity of azoxystrobin and cyproconazole to Prochilodus lineatus: Bioconcentration and biochemical responses.

  2023cites this paper
• IADVL SIG Recalcitrant Dermatophytosis Position Statement on Super Bioavailable Itraconazole

  2023cites this paper
• Systemic Antifungal Therapy for Invasive Pulmonary Infections

  2023influential citation
• Potency of Micro-Gels in Effective Management of Fungal Infection Diseases

  2023cites this paper
• Synergistic effect of miscible cellulose-based microparticles and pH modulators on the bioavailability of a weakly basic drug and its metabolites.

  2023cites this paper
• No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India

  2023cites this paper
• The Optimal Dosing Regimen of Super Bioavailable Itraconazole in Obesity: An Experimental Rat Model Study

  2023cites this paper
• Studies on the interaction of five triazole fungicides with human renal transporters in cells.

  2023cites this paper
• Effect of shear strain on the supercooled itraconazole.

  2023cites this paper
• Validation of a method for itraconazole and major metabolite hydroxyitraconazole for LC-MS/MS analysis with application in a formulation clinical study.

  2023cites this paper
• Self-emulsifying micelles as a drug nanocarrier system for itraconazole oral bioavailability enhancement; in vitro and in vivo assessment

  2023cites this paper
• Therapeutic Updates on the Management of Tinea Corporis or Cruris in the Era of Trichophyton Indotineae: Separating Evidence from Hype—A Narrative Review

  2023cites this paper
• Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis

  2023cites this paper
• Assessment of Antifungal Pharmacodynamics

  2023cites this paper
• Beads and Beyond: An Observational Study to Generate Real World Evidence on Various Brands of Itraconazole

  2022cites this paper
• Improved absorption of itraconazole tablet by co-administration with lemon beverages in a lung transplant recipient: A case report.

  2022cites this paper
• Serum and sebum pharmacokinetics evaluation of a novel formulation of itraconazole in healthy volunteers

  2022cites this paper
• Design Development and Evaluation on Microemulsion Gel of Itraconazole

  2022cites this paper
• Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer

  2022cites this paper
• Osteoarticular Mycoses

  2022cites this paper
• Influence of Gender, Body Mass Index, and Age on the Pharmacokinetics of Itraconazole in Healthy Subjects: Non-Compartmental Versus Compartmental Analysis

  2022influential citation
• Cytochrome P450 reaction phenotyping of itraconazole hydroxylation in the dog.

  2022cites this paper
• Variability of Hydroxy-Itraconazole in Relation to Itraconazole Bloodstream Concentrations

  2021cites this paper
• Predicting a therapeutic cut‐off serum level of itraconazole in recalcitrant tinea corporis and cruris—A prospective trial

  2021cites this paper
• Rapid and Simple Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) Method for Simultaneous Quantifications of Triazole Antifungals in Human Serum

  2021cites this paper
• A comprehensive review on environmental toxicity of azole compounds to fish.

  2021cites this paper
• The API

  2021cites this paper
• The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options.

  2021cites this paper
• Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations

  2021cites this paper
• In vitro and in vivo assessment of hydroxypropyl cellulose as functional additive for enabling formulations containing itraconazole

  2021influential citation
• New In Vitro-In Silico Approach for the Prediction of In Vivo Performance of Drug Combinations

  2021cites this paper
• Exploring novel carrier for improving bioavailability of Itraconazole: Solid dispersion through hot-melt extrusion

  2021cites this paper
• Multiple seborrheic keratosis‐like lesions of mycosis fungoides masquerading as the Leser–Trèlat sign

  2020cites this paper
• Antifungal Therapy: New and Evolving Therapies

  2020cites this paper
• Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.

  2020cites this paper
• Antifungal Drugs

  2020influential citation
• Generalized exfoliative skin rash as an early predictor of supratherapeutic voriconazole trough levels in a leukemic child: A case report

  2020cites this paper
• Subcutaneous Trichophyton rubrum abscesses in an immunocompromised patient

  2020cites this paper
• Administration and Dosing of Systemic Antifungal Agents in Pediatric Patients

  2020cites this paper
• A Simple Approach for Trace Voltammetrical Determination of Itraconazole an Inhibitor of the Cytochrome P-450 14 α-demethylase Enzyme in Formulation and Human Plasma Utilizing Graphene-Carbon Paste Electrode in Situ Modified with an Anionic Surfactant

  2020cites this paper
• Nanoparticles as A Tool for Broadening Antifungal Activities.

  2020cites this paper
• Physiologically Based Precision Dosing Approach for Drug‐Drug‐Gene Interactions: A Simvastatin Network Analysis

  2020cites this paper
• On the Usefulness of Two Small-Scale In Vitro Setups in the Evaluation of Luminal Precipitation of Lipophilic Weak Bases in Early Formulation Development

  2020cites this paper
• A cell-based high-throughput screen identifies drugs that cause bleeding disorders by off-targeting the vitamin K cycle.

  2020cites this paper
• The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy

  2019cites this paper
• Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model

  2019cites this paper
• In vitro analysis of itraconazole cis-diastereoisomers inhibition of nine cytochrome P450 enzymes: stereoselective inhibition of CYP3A

  2019cites this paper
• Model qualification of the PK-Sim® pediatric module for pediatric exposure assessment of CYP450 metabolized compounds

  2019influential citation
• Parameters that determine dissolution and efficacy of itraconazole and its relevance to recalcitrant dermatophytoses

  2019cites this paper
• Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients

  2019cites this paper
• Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.

  2019cites this paper
• Antifungal efficacy of Itraconazole loaded PLGA-nanoparticles stabilized by vitamin-E TPGS: In vitro and ex vivo studies.

  2019cites this paper
• Improved Solubility of Itraconazole Binary Dispersions using Neem Gum: Development and Characterization of Topical Gel

  2019cites this paper
• Assessment of physical and dissolution characteristics of various itraconazole capsule formulations: a comparative analysis

  2019cites this paper
• Antifungal Therapy

  2019cites this paper
• In vitro - in silico approach for the prediction of in vivo performance of drugs

  2018cites this paper
• PBPK Models for CYP3A4 and P‐gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil, and Digoxin

  2018cites this paper
• Systemic Therapy of Onychomycosis

  2018cites this paper
• Itraconazole in combination with neutrophil depletion reduces the expression of genes related to pulmonary fibrosis in an experimental model of paracoccidioidomycosis

  2018cites this paper
• Development and Validation of a Simple and Rapid HPLC Method for Determination of Itraconazole in Bulk and Marketed Formulation

  2018cites this paper
• Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug Interactions

  2018cites this paper
• Antifungal Dosing Considerations in Patients Undergoing Continuous Renal Replacement Therapy

  2018cites this paper
• Isotope-Edited Infrared Spectroscopy for Efficient Discrimination between Pharmaceutical Salts and Cocrystals.

  2017cites this paper
• Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent‐controlled precipitation and spray‐dry methods

  2017cites this paper
• Antifungal Drugs in Newborns and Children.

  2017cites this paper
• Plasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution

  2017cites this paper
• Population in vitro–in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole

  2017cites this paper
• Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice

  2017cites this paper
• Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients

  2017cites this paper
• Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis

  2017cites this paper
• Isotretinoin may affect pharmacokinetics of itraconazole in the skin: Is it rational to combine both for the treatment of dermatophytosis?

  2017cites this paper
• Itraconazole: What clinicians should know?

  2017cites this paper
• Immunomodulatory activity of itraconazole in lung

  2017cites this paper
• In vitro models to describe the pharmacokinetics and pharmacodynamics of new and existing antifungal agents

  2017cites this paper
• Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial

  2017cites this paper
• Softinterface on Biosensing

  2016cites this paper
• Divergence of Antiangiogenic Activity and Hepatotoxicity of Different Stereoisomers of Itraconazole

  2016cites this paper
• Analytical and semipreparative chiral separation of cis-itraconazole on cellulose stationary phases by high-performance liquid chromatography.

  2016cites this paper
• Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction

  2016cites this paper
• Prediction of area under the curve for a p-glycoprotein, a CYP3A4 and a CYP2C9 substrate using a single time point strategy: assessment using fexofenadine, itraconazole and losartan and metabolites

  2016cites this paper
• Antifungal Agents: Spectrum of Activity, Pharmacology, and Clinical Indications.

  2016cites this paper
• Physical stabilization of amorphous itraconazole in solid dispersions for improved dissolution profile

  2016cites this paper